United States · FDA National Drug Code directory
Fexofenadine Hydrochloride and Pseudoephedrine Hydrochloride
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 58602-844_bced0a2e-047e-456e-bbd2-495e83bf07ee
- Product NDC
- 58602-844
- Form
- TABLET, FILM COATED, EXTENDED RELEASE
- Composition / generic term
- Fexofenadine Hydrochloride and Pseudoephedrine Hydrochloride
- Labeler
- Aurohealth LLC
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20250417
- Source listing expiry
- 20261231
Source-listed ingredients
- FEXOFENADINE HYDROCHLORIDE — 180 mg/1
- PSEUDOEPHEDRINE HYDROCHLORIDE — 240 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 1 BLISTER PACK in 1 CARTON (58602-844-60) / 5 TABLET, FILM COATED, EXTENDED RELEASE in 1 BLISTER PACK · 58602-844-60
- 2 BLISTER PACK in 1 CARTON (58602-844-66) / 5 TABLET, FILM COATED, EXTENDED RELEASE in 1 BLISTER PACK · 58602-844-66
- 3 BLISTER PACK in 1 CARTON (58602-844-85) / 5 TABLET, FILM COATED, EXTENDED RELEASE in 1 BLISTER PACK · 58602-844-85
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →